Upstream Bio (UPB) Return on Sales Growth (1y) (2024 - 2026)
Upstream Bio (UPB) Return on Sales Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | 0.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Upstream Bio | 343.92 Mn | 343.92 Mn | -3.94 Mn | 2.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 |
| Dec 31, 2025 | -156.00 |
| Sep 30, 2025 | -111.00 |
| Jun 30, 2025 | -55.00 |
| Mar 31, 2025 | -38.00 |
| Dec 31, 2024 | -34.00 |
| Sep 30, 2024 | -71.00 |